{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-027742","form_type":"8-K","ticker":"REVB","cik":"0001810560","company_name":"REVELATION BIOSCIENCES, INC.","filed_at":"2026-01-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.262282+00:00","generated_at":"2026-05-16T06:31:37.865564+00:00","sec_items":["1.01","3.02","3.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Revelation Biosciences raises ~$7.3M via warrant exercise; issues new warrants","bullets":["Two holders exercised 8,544,999 pre-split Class I warrants at $0.86/share, gross proceeds ~$7.3M.","Company issued 17,089,998 pre-split new Class J warrants at $0.86/share, exercisable only after stockholder approval.","Net proceeds to fund clinical development and working capital.","Third investor withdrew; filing corrects earlier press release that had included them.","Roth Capital Partners received 8% cash fee of gross proceeds as financial advisor."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-027742","json":"https://secwatch.observer/filing/0001193125-26-027742.json","markdown":"https://secwatch.observer/filing/0001193125-26-027742.md","text":"https://secwatch.observer/filing/0001193125-26-027742.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526027742/0001193125-26-027742-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526027742/revb-20260126.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T06:31:37.865564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d05362ae272a752f8008eb4afaf01fd1b1b388b5","claim":"REVELATION BIOSCIENCES, INC. issued 17,089,998 pre-split (4,272,500 post-split) new common stock warrants of warrant to two holders for aggregate gross proceeds of approximately $7.3 million from the exercise of Existing Warrants.","evidence_excerpt":"new common stock warrants (the “Class J Common Stock Warrants”) as described below. The aggregate gross proceeds from the exercise of the Existing Warrants is approximately $7.3 million, before deducting financial advisory fees. The issuance of the Class J Common Stock Warrants was structured as an at-market transaction under Nasdaq rules. The Company intends to","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526027742/0001193125-26-027742-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"17,089,998 pre-split (4,272,500 post-split) new common stock warrants"},{"label":"Purchaser","value":"two holders"},{"label":"Consideration","value":"aggregate gross proceeds of approximately $7.3 million from the exercise of Existing Warrants"}],"fact_type":"equity_issuance"},{"claim_id":"1738e685cb44aa07da7d1fc6e2045bc021b72ab5","claim":"REVELATION BIOSCIENCES, INC. entered into Inducement Letters with two holders valued at approximately $7.3 million (effective 2026-01-23).","evidence_excerpt":"On January 23, 2026, Revelation Biosciences, Inc. (the “Company”) entered into warrant exercise inducement offer letters (the “Inducement Letters”) with two holders","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1810560/000119312526027742/0001193125-26-027742-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"two holders"},{"label":"Value","value":"approximately $7.3 million"},{"label":"Effective","value":"2026-01-23"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}